cdp 840 has been researched along with catechol in 1 studies
| Studies (cdp 840) | Trials (cdp 840) | Recent Studies (post-2010) (cdp 840) | Studies (catechol) | Trials (catechol) | Recent Studies (post-2010) (catechol) |
|---|---|---|---|---|---|
| 17 | 1 | 0 | 2,175 | 5 | 867 |
| Protein | Taxonomy | cdp 840 (IC50) | catechol (IC50) |
|---|---|---|---|
| Carbonic anhydrase 1 | Homo sapiens (human) | 5.79 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 5.79 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 0.868 | |
| Carbonic anhydrase 6 | Homo sapiens (human) | 5.79 | |
| Glutaminyl-peptide cyclotransferase | Homo sapiens (human) | 5 | |
| Carbonic anhydrase 3 | Bos taurus (cattle) | 5.79 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blouin, M; Chauret, N; Day, S; Ducharme, Y; Guay, D; Li, C; Nicoll-Griffith, DA; Silva, J; Yergey, JA | 1 |
1 other study(ies) available for cdp 840 and catechol
| Article | Year |
|---|---|
Improving metabolic stability of phosphodiesterase-4 inhibitors containing a substituted catechol: prevention of reactive intermediate formation and covalent binding.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Catechols; Cyclic Nucleotide Phosphodiesterases, Type 4; Microsomes, Liver; Molecular Structure; Protein Binding; Pyridines; Rats; Structure-Activity Relationship | 2002 |